222 results on '"Rabin, Harvey R."'
Search Results
2. A practical approach to interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for postoperative spine infection
3. The routine clinical use of fluorodeoxyglucose PET/CT to confirm treatment response in pyogenic spine infection
4. Measuring the burden of cystic fibrosis: A scoping review
5. The natural history and genetic diversity of Haemophilus influenzae infecting the airways of adults with cystic fibrosis
6. The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection
7. Culture-enriched metagenomic sequencing enables in-depth profiling of the cystic fibrosis lung microbiota
8. Azithromycin and the microbiota of cystic fibrosis sputum
9. The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome
10. A practical approach to interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for postoperative spine infection.
11. Pattern-Based Interpretation Criteria for 18F-Fludeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Pyogenic Spine Infection
12. Diagnostic challenges in pyogenic spinal infection: an expanded role for FDG-PET/CT
13. Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation
14. Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic Spine Infection
15. Stenotrophomonas maltophilia natural history and evolution in the airways of adults with cystic fibrosis.
16. A Polymicrobial Perspective of Pulmonary Infections Exposes an Enigmatic Pathogen in Cystic Fibrosis Patients
17. The genus Prevotella in cystic fibrosis airways
18. Additional file 1 of Azithromycin and the microbiota of cystic fibrosis sputum
19. Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial)
20. Stenotrophomonas maltophilia in Cystic Fibrosis: Guilty or Innocent?
21. Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
22. Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission
23. Azithromycin paradox in the treatment of cystic fibrosis airway disease
24. McKay agar enables routine quantification of the ‘Streptococcus milleri’ group in cystic fibrosis patients
25. The Streptococcus milleri Group—An Unrecognized Cause of Disease in Cystic Fibrosis: A Case Series and Literature Review
26. POLYMICROBIAL INTERACTIONS IN CF: SYNERGIES AND ANTAGONISMS IN HOST RESPONSE: S11.2
27. CYSTIC FIBROSIS AND EATING DISORDERS: A CASE PRESENTATION: S7.2
28. Incidence, impact and natural history ofKlebsiellaspecies infections in cystic fibrosis: A longitudinal single center study
29. Effect of freezing sputum on Pseudomonas aeruginosa population heterogeneity
30. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis
31. Epidemiology and natural history ofPseudomonas aeruginosaairway infections in non-cystic fibrosis bronchiectasis
32. Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
33. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years
34. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
35. Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
36. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response
37. Household Transmission of Streptococcus pneumoniae, Alberta, Canada
38. Virulence adaptations of Pseudomonas aeruginosa isolated from patients with non-cystic fibrosis bronchiectasis
39. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis
40. Long-term clinical outcomes of ‘Prairie Epidemic Strain’Pseudomonas aeruginosainfection in adults with cystic fibrosis
41. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections
42. Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis
43. Incidence, impact and natural history of Klebsiellaspecies infections in cystic fibrosis: A longitudinal single center study
44. Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis
45. Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis
46. Antibiotic susceptibility and molecular mechanisms of macrolide resistance in streptococci isolated from adult cystic fibrosis patients
47. Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study
48. Noninvasive Methods, including Transient Elastography, for the Detection of Liver Disease in Adults with Cystic Fibrosis
49. Long-term clinical outcomes of 'Prairie Epidemic Strain' infection in adults with cystic fibrosis.
50. Twenty-Five-Year Outbreak of Pseudomonas aeruginosa Infecting Individuals with Cystic Fibrosis: Identification of the Prairie Epidemic Strain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.